Literature DB >> 16870077

Multivariate models of health-related utility and the fear of hypoglycaemia in people with diabetes.

Craig J Currie1, Christopher Ll Morgan, Chris D Poole, Peter Sharplin, Morten Lammert, Phil McEwan.   

Abstract

AIM: The aim was to statistically model the degree of fear of hypoglycaemia experienced by people with diabetes, and then model the resulting change in health-related utility associated with differing severity and frequency of hypoglycaemia.
METHODS: The study used pooled data from two previous postal surveys among subjects with confirmed diabetes conducted in Cardiff, UK (n = 1305 responses). The fear of hypoglycaemia was characterised using the Hypoglycaemia Fear Survey (HFS [eight question worry sub-scale only]), and health-related utility using the EQ5D(index). The data were then analysed using univariate and multivariate analysis.
RESULTS: Following detailed preliminary analysis, a two-stage approach was used since fear was important when estimating the EQ5D(index). Fear was then modelled as a function of the severity and frequency of hypoglycaemia while controlling for other factors such as diabetes-related complications. Each severe hypoglycaemic event resulted in a change of 5.881 units on the HFS. One or more symptomatic hypoglycaemic events over the same period results in a corresponding change of 1.773 units on the HFS. A 1 unit increase on the HFS results in a 0.008 unit decrease on the EQ5D(index).
CONCLUSION: While controlling for other factors, the fear of hypoglycaemia was an important determinant of health-related utility. The magnitude of fear of hypoglycaemia was associated with the severity and frequency of hypoglycaemia. Hypoglycaemia was associated with a considerable decrement in health-related utility as a function of increased fear. Measures should be taken to minimise the severity and frequency of hypoglycaemia.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16870077     DOI: 10.1185/030079906X115757

Source DB:  PubMed          Journal:  Curr Med Res Opin        ISSN: 0300-7995            Impact factor:   2.580


  73 in total

Review 1.  A meta-analysis of health state valuations for people with diabetes: explaining the variation across methods and implications for economic evaluation.

Authors:  Tom W C Lung; Alison J Hayes; Andrew Hayen; Andrew Farmer; Philip M Clarke
Journal:  Qual Life Res       Date:  2011-04-07       Impact factor: 4.147

2.  Diminishing marginal disutility of hypoglycaemic events: results from a time trade-off survey in five countries.

Authors:  Jørgen T Lauridsen; Jonas Lønborg; Jens Gundgaard; Henrik Holm Jensen
Journal:  Qual Life Res       Date:  2014-05-17       Impact factor: 4.147

3.  Primary care medical home experience and health-related quality of life among adult medicaid patients with type 2 diabetes.

Authors:  Gregory D Stevens; Leiyu Shi; Christina Vane; Xiaoyu Nie; Anne L Peters
Journal:  J Gen Intern Med       Date:  2014-10-15       Impact factor: 5.128

4.  Individualized Glycemic Control for U.S. Adults With Type 2 Diabetes: A Cost-Effectiveness Analysis.

Authors:  Neda Laiteerapong; Jennifer M Cooper; M Reza Skandari; Philip M Clarke; Aaron N Winn; Rochelle N Naylor; Elbert S Huang
Journal:  Ann Intern Med       Date:  2017-12-12       Impact factor: 25.391

5.  Cost effectiveness of saxagliptin and metformin versus sulfonylurea and metformin in the treatment of type 2 diabetes mellitus in Germany: a Cardiff diabetes model analysis.

Authors:  Wilma Erhardt; Klas Bergenheim; Isabelle Duprat-Lomon; Phil McEwan
Journal:  Clin Drug Investig       Date:  2012-03-01       Impact factor: 2.859

6.  Cost-effectiveness of second-line antihyperglycemic therapy in patients with type 2 diabetes mellitus inadequately controlled on metformin.

Authors:  Scott Klarenbach; Chris Cameron; Sumeet Singh; Ehud Ur
Journal:  CMAJ       Date:  2011-10-03       Impact factor: 8.262

Review 7.  Systematic Review of the Cost Effectiveness of Insulin Analogues in Type 1 and Type 2 Diabetes Mellitus.

Authors:  Asrul Akmal Shafie; Chin Hui Ng; Yui Ping Tan; Nathorn Chaiyakunapruk
Journal:  Pharmacoeconomics       Date:  2017-02       Impact factor: 4.981

8.  Cost-effectiveness of insulin analogues for diabetes mellitus.

Authors:  Chris G Cameron; Heather A Bennett
Journal:  CMAJ       Date:  2009-02-17       Impact factor: 8.262

9.  Effect of patients' risks and preferences on health gains with plasma glucose level lowering in type 2 diabetes mellitus.

Authors:  Sandeep Vijan; Jeremy B Sussman; John S Yudkin; Rodney A Hayward
Journal:  JAMA Intern Med       Date:  2014-08       Impact factor: 21.873

10.  Outcomes of adding second hypoglycemic drug after metformin monotherapy failure among type 2 diabetes in Hungary.

Authors:  György Jermendy; Diana Erdesz; Laszlo Nagy; Don Yin; Hemant Phatak; Sudeep Karve; Samuel Engel; Rajesh Balkrishnan
Journal:  Health Qual Life Outcomes       Date:  2008-10-31       Impact factor: 3.186

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.